Cryo-Cell International Q2 EPS $0.03 Beats $(0.08) Estimate, Sales $7.77M Inline
Portfolio Pulse from Benzinga Newsdesk
Cryo-Cell International (NASDAQ:CCEL) reported Q2 earnings of $0.03 per share, beating the analyst consensus estimate of $(0.08) by 137.5%. However, this is a 57.14% decrease from the same period last year. The company's quarterly sales of $7.77 million met the analyst consensus estimate, marking a 1.83% increase from the same period last year.
July 14, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cryo-Cell International's Q2 earnings beat estimates but are down YoY. Sales met estimates and are up YoY.
Cryo-Cell International beat earnings estimates, which is generally positive for the stock. However, the YoY decrease in earnings could be a concern for investors. Sales met estimates and increased YoY, which is a positive sign. The net impact could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100